GleamWall
中文EN

HQY HEALTHEQUITY, INC.

Services-Business Services, NEC · Nasdaq · SEC CIK 1428336 · Fiscal year ends 01/31

Financial factors as of 2026-07-31 (2027Q2), TTM = sum of the last four quarters

Growth

TTM revenue YoY7.3%
TTM net income YoY62.2%
TTM EPS YoY67.9%
Revenue 3-yr CAGR13.2%
Net income 3-yr CAGR164.2%

Margins

Gross margin71.2%
Operating margin25.8%
Net margin17.4%
FCF margin35.8%
EBITDA margin31.5%

Returns

ROE11.4%
ROA7.1%
ROIC (approx.)9.8%
Asset turnover0.41x

Leverage & solvency

Liabilities / assets39.2%
Debt / equity0.47x
Current ratio2.99x
Interest coverage6.69x

Cash quality & payout

Operating cash flow / net income2.07x
Accruals ratio-7.6%
Payout ratio—
Capex / revenue0.2%

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item 2027Q22026-07-312027Q12026-04-302026Q4*2026-01-312026Q32025-10-312026Q22025-07-312026Q12025-04-302025Q4*2025-01-312025Q32024-10-31
Income statement
Revenue$350.73M$354.64M$334.59M$322.16M$325.83M$330.84M$311.82M$300.43M
Cost of revenue$92.78M$98.33M$106.44M$94.10M$93.24M$106.53M$122.77M$103.41M
Gross profit$257.95M$256.31M$228.15M$228.06M$232.59M$224.31M$189.04M$197.03M
R&D expense$73.92M$67.77M$70.35M$65.92M$64.80M$61.44M$64.65M$60.19M
SG&A expense$34.87M$31.13M$33.53M$30.88M$29.99M$25.54M$29.98M$31.79M
Operating income$98.69M$102.95M$71.07M$78.69M$89.61M$83.08M$42.15M$19.62M
Interest expense$12.61M$12.59M$13.27M$14.05M$14.96M$14.86M$15.26M$18.16M
Pretax income$87.86M$92.41M$60.90M$67.53M$78.05M$70.95M$29.96M$6.22M
Income tax$22.22M$23.00M$11.16M$15.84M$18.19M$17.04M$3.60M$515,000
Net income$65.64M$69.42M$49.74M$51.69M$59.85M$53.91M$26.36M$5.70M
EBITDA$99.19M$141.17M$109.75M$79.09M$90.11M$121.82M$81.33M$20.62M
EPS (basic)0.790.82—0.600.690.62—0.07
EPS (diluted)0.780.82—0.590.680.61—0.06
Weighted avg. shares (diluted)84.01M85.01M—86.97M87.75M88.42M—88.63M
Balance sheet
Cash & equivalents$256.00M$265.37M$318.93M$309.26M$304.46M$287.89M$295.95M$322.16M
Receivables$122.19M$122.00M$123.70M$111.24M$111.16M$116.26M$118.01M$106.71M
Current assets$460.20M$466.53M$512.28M$498.71M$492.83M$472.80M$477.75M$495.25M
PP&E, net$4.82M$3.80M$3.18M$3.39M$3.09M$3.17M$3.24M$3.89M
Goodwill$1.65B$1.65B$1.65B$1.65B$1.65B$1.65B$1.65B$1.65B
Intangibles$1.05B$1.07B$1.10B$1.12B$1.15B$1.18B$1.20B$1.23B
Total assets$3.27B$3.31B$3.38B$3.40B$3.42B$3.42B$3.45B$3.49B
Current liabilities$153.78M$135.74M$156.85M$120.63M$116.58M$116.34M$156.32M$154.54M
Short-term debt$0$0$0$0$0$0$0$0
Long-term debt$931.06M$942.66M$957.38M$982.11M$1.01B$1.06B$1.06B$1.08B
Total debt$931.06M$942.66M$957.38M$982.11M$1.01B$1.06B$1.06B$1.08B
Total liabilities$1.28B$1.26B$1.27B$1.26B$1.27B$1.29B$1.33B$1.36B
Shareholders' equity$1.99B$2.05B$2.11B$2.13B$2.15B$2.12B$2.11B$2.12B
Net debt$675.06M$677.29M$638.45M$672.85M$702.37M$768.67M$760.35M$758.88M
Shares outstanding82.91M83.93M85.01M85.61M86.42M86.71M86.54M86.82M
Cash flow statement
Operating cash flow$136.16M$97.53M$117.92M$138.57M$135.87M$64.74M$75.75M$90.55M
Capital expenditure$978,000$362,000$326,000$784,000$773,000$86,000$328,000$294,000
Free cash flow$135.18M$97.16M$117.59M$137.79M$135.09M$64.65M$75.42M$90.26M
Investing cash flow-$25.91M-$13.90M-$8.44M-$11.38M-$11.18M-$16.14M-$13.56M-$12.87M
Financing cash flow-$119.61M-$137.18M-$99.81M-$122.40M-$108.12M-$56.65M-$88.41M-$82.42M
Depreciation & amortization$500,000$38.21M$38.68M$400,000$500,000$38.74M$39.18M$1.00M
Stock-based compensation$22.21M$19.41M$19.12M$20.54M$19.07M$14.34M$21.71M$21.12M
Share buybacks$107.74M$123.31M$81.02M$92.42M$66.75M$59.06M$62.98M$58.51M

Free plan shows the latest 8 periods; Pro shows all 54 🔒

· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.